New study aims to help HIV patients kick the habit for good

NCT ID NCT06598397

Recruiting now Disease control Sponsor: New York University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing a combination of counseling, peer mentoring, text messages, and nicotine replacement therapy to help people with HIV quit smoking. Researchers will enroll 500 smokers living with HIV in New York City to find the most effective and affordable approach. The goal is to improve health outcomes by reducing smoking rates in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nicotine replacement therapy (patch or lozenge)
What this could lead to: If successful, this could provide an effective, low-cost way to help people with HIV quit smoking, improving their overall health and reducing smoking-related risks.
What could go wrong: This is a Phase 4 optimization study, not a test of a new drug. The interventions are behavioral and supportive, so results may vary and quitting success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease nicotine dependence Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HUMAN IMMUNODEFICIENCY VIRUS (HIV) SMOKING CESSATION

Contacts and locations

Locations

New York University School of Global Public Health
RECRUITING

New York, New York, 10003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.